๐ฐ Ip Biotech Group News
Ip Biotech Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ip Biotech Group. Real-time updates on events, politics, business and more.
May 13, 2023
The Omnibus Election Code prohibits donations from those holding active government contracts, while Comelec Resolution No. 10772 only allows domestic companies to make donations not exceeding 5% of their taxable income
March 30, 2022
By 98 percent when administered in 3 doses.
March 24, 2022
The Sinovac-CoronaVac has been granted the emergency use authorization (EUA) by the Food and Drug Administration (FDA) for pediatric Covid-19 inoculation in the Philippines.
March 20, 2022
Davao City waiting for guidelines for Sinovac use for minors
March 14, 2022
The Philippines FDA has granted emergency use authorization to Sinovacโs Covid-19 vaccine, CoronaVac, for use in paediatric individuals.
March 13, 2022
(File photo) MANILA - Sinovac's CoronaVac, a Chinese vaccine against coronavirus disease 2019 (Covid-19), can now be used for pediatric vaccination after getting an approval from Philippine authorities. "We thank the FDA (Food and Drug Administration) and our vaccine experts for approving Sinovac's CoronaVac for ages 6 and above," IP Biotech Group chairman Enrique Gonzales said in a statement Saturday. IP Biotech Group is a pharmaceutical consortium that facilitated the initial...
March 2, 2022
AS the government continues to expand vaccination to minors, the local pharmaceutical importer of the Sinovac Covid vaccine is confident that it will be granted Emergency Use Authorization (EUA) by the Food and Drug Administration (FDA) for children aged six to 17. It was recently granted EUA in Brazil and Thailand.…
March 2, 2022
COVID-19 protection for minors six to 17 years old is within reach as the Sinovac COVID vaccine was given the green light for Emergency Use Authorization (EUA) in Brazil and Thailand which could be the basis for the same EUA in the Philippines. This development can advance the campaign for pediatric
February 24, 2022
(PNA photo by Robert Alfiler) MANILA - The pharmaceutical consortium IP Biotech Group is looking forward to the approval of the coronavirus disease 2019 (Covid-19) vaccine Sinovac for minors that would boost pediatric immunization in the country. In a statement, IP Biotech said the Chinese vaccine has secured emergency use authorization (EUA) for children aged six years to 17 years in Brazil and Thailand, which could be the basis for the same EUA in the country. It added that Sinovac is also bei...